[{"address1": "3600 Green Court", "address2": "Suite 350", "city": "Ann Arbor", "state": "MI", "zip": "48105-1570", "country": "United States", "phone": "734 335 0468", "website": "https://endrainc.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.", "fullTimeEmployees": 21, "maxAge": 86400, "priceHint": 4, "previousClose": 0.1185, "open": 0.1167, "dayLow": 0.1123, "dayHigh": 0.1372, "regularMarketPreviousClose": 0.1185, "regularMarketOpen": 0.1167, "regularMarketDayLow": 0.1123, "regularMarketDayHigh": 0.1372, "beta": 1.06, "forwardPE": -0.7182353, "volume": 14313108, "regularMarketVolume": 14313108, "averageVolume": 17917403, "averageVolume10days": 48791470, "averageDailyVolume10Day": 48791470, "bid": 0.1196, "ask": 0.1229, "bidSize": 3200, "askSize": 3200, "marketCap": 2093209, "fiftyTwoWeekLow": 0.069, "fiftyTwoWeekHigh": 2.79, "fiftyDayAverage": 0.2411, "twoHundredDayAverage": 0.897525, "currency": "USD", "enterpriseValue": 627774, "floatShares": 10033621, "sharesOutstanding": 17143400, "sharesShort": 104677, "sharesShortPriorMonth": 7550, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0095999995, "heldPercentInsiders": 0.16028999, "heldPercentInstitutions": 0.0154, "shortRatio": 0.99, "shortPercentOfFloat": 0.0097, "impliedSharesOutstanding": 17143400, "bookValue": 0.339, "priceToBook": 0.360177, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -9893204, "trailingEps": -0.91, "forwardEps": -0.17, "lastSplitFactor": "1:20", "lastSplitDate": 1670544000, "enterpriseToEbitda": -0.061, "52WeekChange": -0.9227848, "SandP52WeekChange": 0.26238096, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "NDRA", "underlyingSymbol": "NDRA", "shortName": "ENDRA Life Sciences Inc.", "longName": "ENDRA Life Sciences Inc.", "firstTradeDateEpochUtc": 1498829400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "4f58a07b-98f8-33d8-a09e-400537b24390", "messageBoardId": "finmb_52323443", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.1221, "targetHighPrice": 8.0, "targetLowPrice": 8.0, "targetMeanPrice": 8.0, "targetMedianPrice": 8.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 1134701, "totalCashPerShare": 0.103, "ebitda": -10257438, "totalDebt": 415022, "quickRatio": 0.933, "currentRatio": 1.044, "debtToEquity": 11.222, "returnOnAssets": -1.10557, "returnOnEquity": -2.4138, "freeCashflow": -2759802, "operatingCashflow": -9186240, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]